Progress is being made in the development of three-dimensionally (3D)-bioprinted organs, with Tal Dvir at Israel's Tel Aviv University anticipating transplantation-viable organs to become available in a decade.
Milestones to date have included Poland-based researchers’ bioprinting of a functional prototype of a pancreas that realized stable blood flow in pigs, and U.S.-based United Therapeutics’ 3D-printing of a human lung scaffold.
Stanford University's Mark Skylar Scott said, "The ability to place different cell types in precise locations to build up a complex tissue, and the capability of integrating blood vessels that can deliver the necessary oxygen and nutrients to keep cells alive, are two [3D] techniques that are revolutionizing tissue engineering."
View Full Article
Abstracts Copyright © 2023 SmithBucklin, Washington, D.C., USA